High-risk drug use: epidemiological pattern through hair testing in the forensic context
e201911065
Keywords:
Drug use, Hair testing, Drug testing, EpidemiologyAbstract
Background: The basic sources of information on drug use are epidemiological surveys, although they have some limitations: their results may be conditioned by the lack of veracity of the responses and the sampling method makes it difficult to detect low-prevalence behaviours in target populations. This study aimed to establish the epidemiological pattern of drug use in the population undergoing drug testing in hair, in the framework of judicial investigations, in order to provide an additional approach to the knowledge of high-risk drug use.
Methods: A cross-sectional study on drug use was conducted on the population subjected to drug testing in hair (N=5,292) in the forensic context. Prevalence of cannabis, cocaine, heroin, ketamine, amphetamine (AP), methamphetamine (MA), 3,4-methylenedioxy-methamphetamine (MDMA), 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-N-ethylamphetamine (MDEA) and methadone uses were obtained. Association between drug use and demographics, and trends of prevalence over the period were analysed using the Pearson Chi-square test. Frequency distribution of drug concentrations in hair was obtained and it was assessed in relation to gender and age using the non-parametric Mann-Whitney U and Kruskal-Wallis H methods.
Results: During the period 2013-2015, prevalence of cocaine use was particularly high (49%), rating second among the population studied, after cannabis use (54%). Proportions of heroin, methadone, MDMA and amphetamine use ranged from 10% to 18%. There was a significant increase in prevalence of MDMA, heroin and amphetamine use during the period 2013-2015, as well as a significant decrease in methadone use. The rates of cannabis, cocaine and MDMA use were higher in men, whereas methadone use was higher among women.
Conclusions: Cannabis and cocaine are the most frequently abused drugs among the population undergoing drug testing in hair in the framework of judicial investigations over the three-year period, although the proportions of heroin, MDMA and amphetamine users show an increasing trend. Drug use patterns vary according to age and sex, with a decrease in cannabis and MDMA use and an increase in heroin and methadone use as age increased; cannabis, cocaine and MDMA use are more prevalent among men and methadone use among women.
Downloads
References
Fendrich M, Johnson TP, Wislar JS, Hubbell A, Spiehler V. The utility of drug testing in epidemiological research: results from a general population survey. Addiction. 2004;99: 197–208. http://dx.doi.org/10.1046/j.1360-0443.2003.00632.x.
Gjerde H, Øiestad EL, Christophersen AS. Using biological samples in epidemiological research on drugs of abuse. Norsk Epidemiologi. 2011; 1(21): p. 5-14. http://dx.doi.org/10.5324/nje.v21i1.1420
Mieczkowski T. The use of hair analysis for the detection of drugs: an overview. J Clin Forensic Med. 1996; 3: p. 59-71. http://dx.doi.org/10.1016/S1353-1131(96)90009-7.
European Monitoring Centrefor Drugs and Drug Addiction (EMCDDA). High-risk drug use* key epidemiological indicator: PDU (Problem drug use) revision summary. 2013. Disponible en: http://www.emcdda.europa.eu/activities/hrdu. (acceso 8/12/2017).
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Key Epidemiological Indicator: Prevalence of problem drug use. Recommended Draft Technical Tools and Guidelines. 2004. Disponible en: http://www.emcdda.europa.eu/system/files/publications/321/Guidelines_Prevalence_Revision_280704_b-1_124620.pdf. (acceso 8/12/2017).
Grinstead GF. A closer look at acetyl and pentafluoropropionyl derivatives for quantitative analysis of morphine and codeine by Gas Chromatography/Mass Spectrometry. J Anal Toxicol. 1991; 15(6): p. 293-298. https://doi.org/10.1093/jat/15.6.293.
Aderjan RE, Schmitt G, Wu M, Meyer C. Determination of cocaine and benzoylecgonine by derivatization with iodomethane-D3 or PFPA/HFIP in human blood and urine using GC/MS (EI or PCI Mode). J Anal Toxicol. 1993; 17(1): p. 51-55. https://doi.org/10.1093/jat/17.1.51.
Moeller MR, Fey P, Wennig R. Simultaneous determination of drugs of abuse (opiates, cocaine and amphetamine) in human hair by GCMS and its application to a methadone treatment program. Forensic Sci Int. 1993; 63: p. 185-206. http://dx.doi.org/10.1016/0379-0738(93)90273-D.
Burgueño MJ, Alonso A, Sánchez S. Amphetamines and cannabinoids testing in hair: Evaluation of results from a two-year period. Forensic Sci Int. 2016; 265: p. 47–53. http://dx.doi.org/10.1016/j.forsciint.2016.01.003.
Cooper GA, Kronstrand R, Kintz P. Society of Hair Testing guidelines for drug testing in hair. Forensic Sci Int. 2012; 218: p. 20–24. http://dx.doi.org/10.1016/j.forsciint.2011.10.024
European Commission DG Justice. Final Report of the European Drug Emergencies Network (Euro‐DEN). 2015. Disponible en: http://www.emcdda.europa.eu/activities/emergencies#section1. (acceso 8/12/2017).
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Treatment demand indicator (TDI) standard protocol 3.0: Guidelines for reporting data on people entering drug treatment in European countries. 2012. Disponible en: http://www.emcdda.europa.eu/publications/manuals/tdi-protocol-3.0. (acceso 8/12/2017).
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). An overview of the drug-related infectious diseases (DRID) key indicator. 2009. Disponible en: http://www.emcdda.europa.eu/publications/methods/drid-overview. (acceso 8/12/2017).
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). An overview of the drug-related deaths (DRD) key indicator. 2017. Disponible en: http://www.emcdda.europa.eu/publications/methods/drd-overview. (acceso 8/12/2017).
Friguls B, Joya X, Garcia-Serra J, Gómez-Culebras M, Pichini S, Martinez S et al. Assessment of exposure to drugs of abuse during pregnancy by hair analysis in a Mediterranean island. Addiction. 2010; 107: p. 1471–1479. http://dx.doi.org/10.1111/j.1360-0443.2012.03828.x.
Lendoiro E, González-Colmenero E, Concheiro-Guisán A, de Castro A, Cruz A, López-Rivadulla M et al. Maternal hair analysis for the detection of illicit drugs, medicines, and alcohol exposure during pregnancy. Ther Drug Monit. 2013; 35(3): p. 296-304. http://dx.doi.org/10.1097/FTD.0b013e318288453f.
Yacoubian GJ, VanderWall K, Johnson R, Urbach B, Peters RJ. Comparing the validity of self-reported recent drug use between adult and juvenile arrestees. J Psychoactive Drugs. 2003; 35(2): p. 279-84. http://dx.doi.org/10.1080/02791072.2003.10400010.
Tassiopoulos K, Bernstein J, Heeren T, Levenson S, Hingson R, Bernstein E. Hair testing and self-report of cocaine use by heoin users. Addiction. 2004; 99: p. 590-597. http://dx.doi.org/10.1111/j.1360-0443.2004.00685.x.
Musshoff F, Driever F, Lachenmeier K, Lachenmeier D, Banger M, Madea B. Results of hair analyses for drugs of abuse and comparison with self-reports and urine tests. Forensic Sci Int. 2006; 156: p. 118–123. http://dx.doi.org/10.1016/j.forsciint.2004.07.024.
Sharma G, Odena N, VanVeldhuisen PC, Bogenschutzb MP. Hair analysis and its concordance with self-report for drug users presenting in emergency department. Drug Alcohol Depend. 2016; 167: p. 149-55. http://dx.doi.org/10.1016/j.drugalcdep.2016.08.007.
Ledgerwood DM, Goldberger BA, Risk NK, Lewis CE, Kato Price R. Comparison between self-report and hair analysis of illicit drug use in a community sample of middle-aged men. Addict Behav. 2008; 33: p. 1131–1139. http//dx.doi.org/10.1016/j.addbeh.2008.04.009.
Observatorio Español de las Drogas y las Toxicomanías. Plan Nacional sobre Drogas. (2015). Alcohol, tabaco y drogas ilegales en España. Estadísticas 2015. Ministerio de Sanidad, Servicios Sociales e Igualdad, Secretaría de Estado de Servicios Sociales e Igualdad, Delegación del Gobierno para el Plan Nacional sobre Drogas. Disponible en: http://www.pnsd.msssi.gob.es/ca/profesionales/sistemasInformacion/informesEstadisticas/pdf/ESTADISTICAS_2015.pdf. (acceso 25/02/2017).
Delegación del Gobierno para el Plan Nacional sobre Drogas. (2011). Encuesta sobre salud y consumo de drogas a los internados en instituciones penitenciarias (ESDIP). Disponible en: http://www.pnsd.msssi.gob.es/profesionales/sistemasInformacion/sistemaInformacion/pdf/ESDIP_2011.pdf. (acceso 06/03/2017).
Delegación del Gobierno para el Plan Nacional sobre Drogas. (2016). Encuesta sobre salud y consumo de drogas a los internados en instituciones penitenciarias (ESDIP). Disponible en: http://www.pnsd.mscbs.gob.es/profesionales/sistemasInformacion/sistemaInformacion/pdf/2016ESDIP.pdf (acceso 13/04/2019).
Tsanaclis L, Wicks JF. Patterns in drug use in the United Kingdom as revealed through analysis of hair in a large population sample. Forensic Sci Int. 2007; 170: p. 121–128. http://dx.doi.org/10.1016/j.forsciint.2007.03.033.
Tassoni G, Mirtella D, Zampi M, Ferrante L, Cippitelli M, Cognigni E et al. Hair analysis in order to evaluate drug abuse in driver’s license regranting procedures. Forensic Sci Int. 2014; 244: p. 16-19. http://dx.doi.org/10.1016/j.forsciint.2014.07.025.
Agius R. Utility of coloured hair for detection of drugs and alcohol. Drug Test Anal. 2014; 6 : p. 110–119. http://dx.doi.org/10.1002/dta.1654.
Jurado C. Forensic applications of hair analysis. In Kintz P, Salomone A, Vincenti M. Hair analysis in clinical and forensic toxicology. London: Academic Press, Elsevier; 2015. p. 241-273.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Perspectives on drugs. Characteristics of frequent and high-risk cannabis users. 2013. Disponible en: http://www.emcdda.europa.eu/topics/pods/frequent-cannabis-users. (acceso 25/03/2017).
Observatorio Español de las Drogas y las Toxicomanías. Plan Nacional sobre Drogas. (2015). Alcohol, tabaco y drogas ilegales en España. Informe 2015. Disponible en: http://www.pnsd.msssi.gob.es/profesionales/sistemasInformacion/informesEstadisticas/pdf/INFORME_2015.pdf. (acceso 26/11/2017).
Downloads
Published
How to Cite
License
Copyright (c) 2019 M. José Burgueño, Sergio Sánchez, M. Ángeles Castro, Ramona Mateos-Campos
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
